Complementing this, editorial perspectives stress the need for longitudinal studies and multi-omic profiling to further elucidate the biological mechanisms linking EAT to myocardial disease, while also highlighting ethnic variability and the modifying effects of pharmacologic agents such as GLP-1 receptor agonists [53]. The gene discussed is GLP1R; the disease is myocardial disorder.